OxyContin manufacturer Purdue Pharma generated more than $10 billion since 2008 for the Sackler family members who own the company, a report said
OxyContin manufacturer Purdue Pharma LP generated more than $10 billion since 2008 for the Sackler family members who own the company, according to a report that will influence the debate among state and local governments over how much of that money should be returned.
The report, written by Purdue adviser AlixPartners LLP and filed in a New York bankruptcy court Monday, is the most thorough accounting yet of dividends collected by the controlling Sackler family during years in which opioid consumption grew into a nationwide...
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
Purdue Pharma’s foreign affiliate now selling overdose cureThe gleaming white booth towered over the medical conference in Italy in October, advertising a new brand of antidote for opioid overdoses. “Be prepared. Get naloxone. Save a life,” the slogan on...
Leer más »
Purdue Pharma’s foreign affiliate now selling overdose cureThe gleaming white booth towered over the medical conference in Italy in October, advertising a new brand of antidote for opioid overdoses. “Be prepared. Get naloxone. Save a life,” the slogan on...
Leer más »
Sackler-owned opioid maker goes global with OD treatmentA Purdue Pharma affiliate has expanded abroad, selling addictive opioids using some of the tactics that made its owners among the world's richest. From Europe to Australia, Mundipharma also aims to dominate the opioid overdose treatment market.
Leer más »